A preliminary study on the prognostic significance of cysteine-rich EGF ligand domain 2 protein (CRELD2) in patients with triple negative breast cancer. Biomol Biomed [Internet]. 2025 May 8 [cited 2025 May 21];25(7):1663–1671. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/11865